Vault-13

Birchview Capital, LP

BURLINGTON, VT · CIK 1618205 · 13F filing filed 2022-05-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$138.9m reported value -10.4% vs Q4 2021
63positions
71.9%in top 10
1 new 14 added 5 reduced 5 sold out vs Q4 2021

Holdings, Q1 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BRISTOL-MYERS SQUIBB CO COM BMY BMY 754,106 $55.1m39.65% 39.65% ReducedShares held: Q2 2021 796.1k, Q3 2021 796.1k, Q4 2021 766.1k, Q1 2022 754.1k -12.0k -12,000 -1.6%
2 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 89,240 $8.4m6.02% 6.02% AddedShares held: Q2 2021 80.2k, Q3 2021 80.2k, Q4 2021 89.2k, Q1 2022 89.2k +40 +40 0.0%
3 ELUTIA INC CL A COM ELUT ELUT 1,417,923 $8.3m5.96% 5.96% UnchangedShares held: Q2 2021 30.0k, Q3 2021 50.0k, Q4 2021 1.4m, Q1 2022 1.4m
4 QUIDEL CORP COM QDEL QDEL 59,684 $6.7m4.83% 4.83% UnchangedShares held: Q2 2021 59.7k, Q3 2021 59.7k, Q4 2021 59.7k, Q1 2022 59.7k
5 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 199,400 $4.8m3.48% 3.48% UnchangedShares held: Q2 2021 199.4k, Q3 2021 199.4k, Q4 2021 199.4k, Q1 2022 199.4k
6 FOGHORN THERAPEUTICS INC COM FHTX FHTX 294,143 $4.5m3.23% 3.23% ReducedShares held: Q2 2021 314.1k, Q3 2021 314.1k, Q4 2021 314.1k, Q1 2022 294.1k -20.0k -20,000 -6.4%
7 ALBIREO PHARMA INC COM BIOD BIOD 113,000 $3.4m2.43% 2.43% UnchangedShares held: Q2 2021 111.0k, Q3 2021 113.0k, Q4 2021 113.0k, Q1 2022 113.0k
8 ACCELERATE DIAGNOSTICS INC COM COM 2,252,388 $3.2m2.33% 2.33% UnchangedShares held: Q2 2021 2.2m, Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m
9 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 18,000 $3.2m2.32% 2.32% UnchangedShares held: Q2 2021 18.0k, Q3 2021 18.0k, Q4 2021 18.0k, Q1 2022 18.0k
10 CONTINENTAL RES INC COM CLR CLR 38,600 $2.4m1.70% 1.70% UnchangedShares held: Q2 2021 38.6k, Q3 2021 38.6k, Q4 2021 38.6k, Q1 2022 38.6k
11 BIOGEN INC COM BIIB BIIB 10,100 $2.1m1.53% 1.53% ReducedShares held: Q2 2021 12.1k, Q3 2021 12.6k, Q4 2021 12.6k, Q1 2022 10.1k -2.5k -2,500 -19.8%
12 BIODESIX INC COM COM 1,252,753 $2.1m1.52% 1.52% UnchangedShares held: Q2 2021 1.1m, Q3 2021 1.1m, Q4 2021 1.3m, Q1 2022 1.3m
13 KARYOPHARM THERAPEUTICS INC COM COM 269,332 $2.0m1.43% 1.43% AddedShares held: Q2 2021 230.0k, Q3 2021 246.0k, Q4 2021 246.0k, Q1 2022 269.3k +23.3k +23,332 9.5%
14 OVINTIV INC COM OVV OVV 34,200 $1.8m1.33% 1.33% UnchangedShares held: Q2 2021 34.2k, Q3 2021 34.2k, Q4 2021 34.2k, Q1 2022 34.2k
15 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 14,000 $1.7m1.20% 1.20% AddedShares held: Q2 2021 10.0k, Q3 2021 10.0k, Q4 2021 12.0k, Q1 2022 14.0k +2.0k +2,000 16.7%
16 PROTHENA CORP PLC SHS PRTA PRTA 41,978 $1.5m1.11% 1.11% AddedShares held: Q2 2021 30.2k, Q3 2021 40.2k, Q4 2021 40.2k, Q1 2022 42.0k +1.7k +1,731 4.3%
17 MASIMO CORP COM MASI MASI 9,280 $1.4m0.97% 0.97% AddedShares held: Q2 2021 8.0k, Q3 2021 8.0k, Q4 2021 8.0k, Q1 2022 9.3k +1.3k +1,280 16.0%
18 ALKERMES PLC SHS ALKS ALKS 50,000 $1.3m0.95% 0.95% UnchangedShares held: Q2 2021 50.0k, Q3 2021 50.0k, Q4 2021 50.0k, Q1 2022 50.0k
19 HARROW INC COM HROW HROW 180,000 $1.2m0.88% 0.88% UnchangedShares held: Q2 2021 180.0k, Q3 2021 180.0k, Q4 2021 180.0k, Q1 2022 180.0k
20 CORCEPT THERAPEUTICS INC COM CORT CORT 50,000 $1.1m0.81% 0.81% UnchangedShares held: Q2 2021 50.0k, Q3 2021 50.0k, Q4 2021 50.0k, Q1 2022 50.0k
21 INHIBRX INC COM INBX INBX 50,448 $1.1m0.81% 0.81% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 40.0k, Q1 2022 50.4k +10.4k +10,448 26.1%
22 EQUITRANS MIDSTREAM CORP COM ETRN ETRN 133,050 $1.1m0.81% 0.81% UnchangedShares held: Q2 2021 133.1k, Q3 2021 133.1k, Q4 2021 133.1k, Q1 2022 133.1k
23 GOSSAMER BIO INC COM GOSS GOSS 129,088 $1.1m0.81% 0.81% AddedShares held: Q2 2021 0, Q3 2021 40.0k, Q4 2021 100.0k, Q1 2022 129.1k +29.1k +29,088 29.1%
24 DOCGO INC COM DCGO DCGO 110,000 $1.0m0.73% 0.73% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 10.0k, Q1 2022 110.0k +100.0k +100,000 1000.0%
25 ARVINAS INC COM ARVN ARVN 15,000 $1.0m0.73% 0.73% UnchangedShares held: Q2 2021 15.0k, Q3 2021 15.0k, Q4 2021 15.0k, Q1 2022 15.0k
26 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 300,000 $987.0k0.71% 0.71% UnchangedShares held: Q2 2021 300.0k, Q3 2021 300.0k, Q4 2021 300.0k, Q1 2022 300.0k
27 PIONEER NAT RES CO COM PXD PXD 3,800 $950.0k0.68% 0.68% UnchangedShares held: Q2 2021 3.8k, Q3 2021 3.8k, Q4 2021 3.8k, Q1 2022 3.8k
28 CYTOKINETICS INC COM NEW CYTK CYTK 25,000 $920.0k0.66% 0.66% UnchangedShares held: Q2 2021 10.0k, Q3 2021 25.0k, Q4 2021 25.0k, Q1 2022 25.0k
29 IMMUNOGEN INC COM IMGN IMGN 190,000 $904.0k0.65% 0.65% UnchangedShares held: Q2 2021 190.0k, Q3 2021 190.0k, Q4 2021 190.0k, Q1 2022 190.0k
30 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 38,000 $900.0k0.65% 0.65% UnchangedShares held: Q2 2021 10.0k, Q3 2021 38.0k, Q4 2021 38.0k, Q1 2022 38.0k
31 SOLENO THERAPEUTICS INC COM COM 3,676,899 $820.0k0.59% 0.59% AddedShares held: Q2 2021 876.9k, Q3 2021 876.9k, Q4 2021 876.9k, Q1 2022 3.7m +2.8m +2,800,000 319.3%
32 AVEO PHARMACEUTICALS INC COM NEW AVEO AVEO 140,000 $783.0k0.56% 0.56% UnchangedShares held: Q2 2021 0, Q3 2021 40.0k, Q4 2021 140.0k, Q1 2022 140.0k
33 CONTRAFECT CORP COM CFRX CFRX 200,000 $730.0k0.53% 0.53% UnchangedShares held: Q2 2021 200.0k, Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k
34 INARI MED INC COM NARI NARI 8,000 $725.0k0.52% 0.52% AddedShares held: Q2 2021 7.0k, Q3 2021 7.0k, Q4 2021 7.0k, Q1 2022 8.0k +1.0k +1,000 14.3%
35 NEKTAR THERAPEUTICS COM COM 128,000 $690.0k0.50% 0.50% AddedShares held: Q2 2021 72.0k, Q3 2021 72.0k, Q4 2021 100.0k, Q1 2022 128.0k +28.0k +28,000 28.0%
36 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 4,000 $630.0k0.45% 0.45% UnchangedShares held: Q2 2021 0, Q3 2021 4.0k, Q4 2021 4.0k, Q1 2022 4.0k
37 APELLIS PHARMACEUTICALS INC COM APLS APLS 12,000 $610.0k0.44% 0.44% UnchangedShares held: Q2 2021 8.0k, Q3 2021 12.0k, Q4 2021 12.0k, Q1 2022 12.0k
38 KALVISTA PHARMACEUTICALS INC COM KALV KALV 40,000 $590.0k0.42% 0.42% UnchangedShares held: Q2 2021 40.0k, Q3 2021 40.0k, Q4 2021 40.0k, Q1 2022 40.0k
39 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 34,333 $586.0k0.42% 0.42% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 28.0k, Q1 2022 34.3k +6.3k +6,334 22.6%
40 VANDA PHARMACEUTICALS INC COM VNDA VNDA 50,000 $566.0k0.41% 0.41% ReducedShares held: Q2 2021 80.0k, Q3 2021 80.0k, Q4 2021 60.0k, Q1 2022 50.0k -10.0k -10,000 -16.7%
41 CHEMOCENTRYX INC COM CCXI CCXI 20,000 $501.0k0.36% 0.36% UnchangedShares held: Q2 2021 30.0k, Q3 2021 25.0k, Q4 2021 20.0k, Q1 2022 20.0k
42 CULLINAN THERAPEUTICS INC COM CGEM CGEM 45,114 $472.0k0.34% 0.34% UnchangedShares held: Q2 2021 45.1k, Q3 2021 45.1k, Q4 2021 45.1k, Q1 2022 45.1k
43 SILK RD MED INC COM SILK SILK 10,000 $413.0k0.30% 0.30% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 8.0k, Q1 2022 10.0k +2.0k +2,000 25.0%
44 BLUEBIRD BIO INC COM COM 84,000 $407.0k0.29% 0.29% UnchangedShares held: Q2 2021 74.0k, Q3 2021 84.0k, Q4 2021 84.0k, Q1 2022 84.0k
45 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 8,000 $369.0k0.27% 0.27% UnchangedShares held: Q2 2021 8.0k, Q3 2021 8.0k, Q4 2021 8.0k, Q1 2022 8.0k
46 AMICUS THERAPEUTICS INC COM FOLD FOLD 38,000 $360.0k0.26% 0.26% UnchangedShares held: Q2 2021 38.0k, Q3 2021 38.0k, Q4 2021 38.0k, Q1 2022 38.0k
47 VENTYX BIOSCIENCES INC COM VTYX VTYX 25,000 $339.0k0.24% 0.24% UnchangedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 25.0k, Q1 2022 25.0k
48 XENCOR INC COM XNCR XNCR 12,300 $328.0k0.24% 0.24% UnchangedShares held: Q2 2021 12.3k, Q3 2021 12.3k, Q4 2021 12.3k, Q1 2022 12.3k
49 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 20,000 $325.0k0.23% 0.23% UnchangedShares held: Q2 2021 20.0k, Q3 2021 20.0k, Q4 2021 20.0k, Q1 2022 20.0k
50 STOKE THERAPEUTICS INC COM STOK STOK 15,000 $316.0k0.23% 0.23% UnchangedShares held: Q2 2021 15.0k, Q3 2021 15.0k, Q4 2021 15.0k, Q1 2022 15.0k
51 G1 THERAPEUTICS INC COM GTHX GTHX 40,000 $304.0k0.22% 0.22% UnchangedShares held: Q2 2021 40.0k, Q3 2021 40.0k, Q4 2021 40.0k, Q1 2022 40.0k
52 KINIKSA PHARMACEUTICALS LTD COM CL A COM CL A 30,000 $298.0k0.21% 0.21% UnchangedShares held: Q2 2021 20.0k, Q3 2021 30.0k, Q4 2021 30.0k, Q1 2022 30.0k
53 PHREESIA INC COM PHR PHR 10,000 $264.0k0.19% 0.19% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 10.0k
54 IVERIC BIO INC COM OPHT OPHT 15,000 $252.0k0.18% 0.18% UnchangedShares held: Q2 2021 0, Q3 2021 15.0k, Q4 2021 15.0k, Q1 2022 15.0k
55 TURNING POINT THERAPEUTICS I COM COM 8,000 $215.0k0.15% 0.15% UnchangedShares held: Q2 2021 8.0k, Q3 2021 8.0k, Q4 2021 8.0k, Q1 2022 8.0k
56 INFLARX NV COM IFRX IFRX 70,000 $128.0k0.09% 0.09% UnchangedShares held: Q2 2021 70.0k, Q3 2021 70.0k, Q4 2021 70.0k, Q1 2022 70.0k
57 ANGION BIOMEDICA CORP COM COM 54,392 $115.0k0.08% 0.08% UnchangedShares held: Q2 2021 60.6k, Q3 2021 54.4k, Q4 2021 54.4k, Q1 2022 54.4k
58 ASPIRA WOMENS HEALTH INC COM COM 103,104 $107.0k0.08% 0.08% UnchangedShares held: Q2 2021 103.1k, Q3 2021 103.1k, Q4 2021 103.1k, Q1 2022 103.1k
59 LAIRD SUPERFOOD INC COM STK LSF LSF 28,000 $101.0k0.07% 0.07% AddedShares held: Q2 2021 14.0k, Q3 2021 14.0k, Q4 2021 18.0k, Q1 2022 28.0k +10.0k +10,000 55.6%
60 YIELD10 BIOSCIENCE INC COM COM 18,750 $99.0k0.07% 0.07% UnchangedShares held: Q2 2021 0, Q3 2021 18.8k, Q4 2021 18.8k, Q1 2022 18.8k
61 SIENTRA INC COM SIEN SIEN 40,000 $89.0k0.06% 0.06% UnchangedShares held: Q2 2021 40.0k, Q3 2021 40.0k, Q4 2021 40.0k, Q1 2022 40.0k
62 CONCERT PHARMACEUTICALS INC COM CNCE CNCE 20,000 $67.0k0.05% 0.05% UnchangedShares held: Q2 2021 20.0k, Q3 2021 20.0k, Q4 2021 20.0k, Q1 2022 20.0k
63 AKEBIA THERAPEUTICS INC COM AKBA AKBA 20,000 $14.0k0.01% 0.01% ReducedShares held: Q2 2021 100.0k, Q3 2021 100.0k, Q4 2021 100.0k, Q1 2022 20.0k -80.0k -80,000 -80.0%

Sold out since Q4 2021

SecurityTickerShares held beforeValue then
ARENA PHARMACEUTICALS INC ARNA ARNA 22,000 $2.0m22.0k shares
PROGYNY INC PGNY PGNY 15,000 $755.0k15.0k shares
TG THERAPEUTICS INC TGTX TGTX 15,000 $285.0k15.0k shares
PFIZER INC PFE PFE 4,000 $236.0k4.0k shares
THERAPEUTICSMD INC TXMD TXMD 50,000 $18.0k50.0k shares